Ameriprise Financial Inc Takeda Pharmaceutical CO LTD Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ameriprise Financial Inc holds 74,292 shares of TAK stock, worth $985,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,292

Previous 54,588 36.1%

Holding current value

$985,111

Previous $706,000 49.43%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $256,152 - $297,136	19,704 Added 36.1%	74,292 $1.06 Million
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $401,310 - $435,389	-31,850 Reduced 36.85%	54,588 $706,000
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $68,686 - $74,372	4,945 Added 6.07%	86,438 $1.2 Million
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $13,760 - $15,892	1,030 Added 1.28%	81,493 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $65,425 - $71,040	4,353 Added 5.72%	80,463 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $49,901 - $54,837	3,205 Added 4.4%	76,110 $1.2 Million
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $396,027 - $427,128	-25,918 Reduced 26.23%	72,905 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $160,950 - $202,419	-12,959 Reduced 11.59%	98,823 $1.54 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $664,537 - $1.49 Million	51,917 Added 86.72%	111,782 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $273,132 - $312,894	-20,818 Reduced 25.8%	59,865 $840,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $217,953 - $247,088	16,097 Added 24.92%	80,683 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $109,521 - $136,382	-8,316 Reduced 11.41%	64,586 $885,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $173,383 - $183,594	10,637 Added 17.08%	72,902 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $24,957 - $28,109	1,508 Added 2.48%	62,265 $1.05 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $275,414 - $327,991	16,482 Added 37.23%	60,757 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $211,612 - $260,837	-13,750 Reduced 23.7%	44,275 $807,000
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $2.14 Million - $2.4 Million	-125,318 Reduced 68.35%	58,025 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $2.01 Million - $2.69 Million	137,989 Added 304.25%	183,343 $3.29 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $5,598 - $8,733	-430 Reduced 0.94%	45,354 $688,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $63,283 - $78,091	-3,749 Reduced 7.57%	45,784 $904,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $84,286 - $93,889	-5,219 Reduced 9.53%	49,533 $851,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $1.17 Million - $1.44 Million	-70,307 Reduced 56.22%	54,752 $969,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $201,552 - $259,724	12,069 Added 10.68%	125,059 $2.55 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $1.77 Million - $2.38 Million	112,990 New	112,990 $1.9 Million

Others Institutions Holding TAK

# of Institutions

339

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Takeda Pharmaceutical CO LTD Transaction History